6 3.5. The risk score was divided into low-risk [0-4 points, n ¼ 5,272 (52%); NHD ¼ 10.1%] moderate-risk [5-9 points, n ¼ 3663 (36.7%) NHD ¼ 36.7%], and high-risk [10 points, n ¼ 1210 (11.9%) NHD ¼ 66.1%).
Objectives: Below-knee amputation (BKA) for lower extremity infection may be performed as a single operation, or as a two-stage procedure with guillotine amputation and subsequent formalization. BKA failure owing to recurrent infection or necrosis is associated with significant morbidity; however, it is unclear whether the potential benefits of staging outweigh the risk of an additional operation. Here, we compare the effectiveness of two-stage BKA to single-stage BKA for lower extremity infection.
Methods: A retrospective review was performed of all patients who underwent BKA for lower extremity infection at our urban limb salvage center from 2011 to 2016. The study population was divided into those who underwent two-stage BKA versus those who underwent single-stage BKA. The primary end point was failure of the BKA surgery, defined as need for surgical revision, unplanned conversion to above-knee amputation (AKA), or mortality within six weeks. Secondary end points included postoperative complications and time to discharge.
Results: Of 205 limbs among 198 patients in the study, 100 (48.8%) underwent single-stage BKA and 105 (51.2%) underwent two-stage BKA. There was no significant difference in age, Charleston Comorbidity Index, or American Society of Anesthesiologists score between groups. Two-stage operations had higher rates of leukocytosis (P < .001), and diabetes (P < .001) with perioperative hyperglycemia (P < .001). Of the 19 BKAs that failed (9.3%), 12 occurred after single-stage amputation (16.6%) versus 7 after two-stage amputation (8.4%); this was not significant (P ¼ .18). There was no difference in the incidence of perioperative mortality or major complications (7.6% two-stage vs 7.0% one-stage; P ¼ .86). In the subset of patients with systemic infection as evidenced by perioperative leukocytosis (155 limbs, 75.6%), a significant reduction in failure was associated with two-stage amputation (4.8% two-stage vs 13.8% one-stage; P ¼ .048), but this was not preserved in the absence of leukocytosis (7% one-stage vs 13.6% two-stage; P ¼ .69). Two-stage BKA was associated with longer hospital stays (17.5 vs 13.7 days; P ¼ .006), greater transfusion need (P ¼ .045) and higher rates of acute kidney injury (P ¼ .045).
Conclusions: In this retrospective study, two-stage below-knee amputation was not associated with lower rates of BKA failure compared with single-stage operation, and was associated with higher rates of certain complications and a longer hospital stay. Although two-stage BKA seems to be the operation of choice in the setting of systemic infection, this benefit was not seen for only local infection.
Further prospective research will help to more clearly identify the subset of patients with foot infections that may safely undergo a singlestage BKA.
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Evaluation of Incomplete Lower Extremity Duplex Venous Ultrasound Examinations
Khanh P. Nguyen, Jacob Weber, David Louie, Rikki Samuel, Nai Saephan, Timothy K. Liem, Gregory J. Landry, Gregory L. Moneta. Oregon Health & Science University, Portland, Ore
Objectives: Deep venous thrombosis (DVT) positive lower extremity venous duplex ultrasound (LEVDUS) examination is an indication for anticoagulation. Incomplete examinations that fail to examine all LE veins in patients not otherwise indicated for anticoagulation may be followed by a repeat examination to exclude missed/progressing DVT. This study examined the frequency of follow-up LEVDUS following incomplete LEV-DUS and compared the incidence of positive DVT between initial complete LEVDUS and follow-up LEVDUS after an initial incomplete examination to determine if improving rates of follow-up LEVDUS following an incomplete examination is a reasonable target for quality improvement.
Methods: From December 2016 to December 2017, incomplete LEVDUS were prospectively identified in patients who did not have an identified indication for anticoagulation. We determined the frequency/ demographics of repeat studies performed within 2 weeks after incomplete LEVDUS and DVT rates of initial and repeat LEVDUS.
Results: There were 4,828 LEVDUS studies (ankle to groin) performed; 223 (4.8%) were incomplete and did not otherwise identify DVT in the ipsilateral or contralateral leg. Of incomplete studies, 80.3% were ordered in-hospital, 12.1% from outpatient clinics, 7.6% from the ED, with 9.9% ordered by primary care providers, 33.6% by specialists, 29.1% by trauma surgeons and 27.4% by emergency department providers. Initial indications for incomplete studies were high-risk screening in 52.5%, and LE signs/symptoms in 47.5%. In addition, 63.2% of incomplete studies resulted from bandages, wounds, braces, casts or fixation devices, 13.5% from edema, 5.8 % from body habitus and 12.1% from patient study intolerance. Deep veins inadequately evaluated on initial LEVDUS included femoral (36.8%), popliteal (40%) and axial calf veins (85.7%). Sixty-one patients (27.3%) with incomplete LEVDUS had repeat examinations. 11.5% had thrombi detected with six in deep and two in superficial veins. Only 18 of 105 symptomatic patients with an incomplete study had a repeat study with 71% of follow-up studies for screening patients (P < .001). DVT diagnosis rates were similar between initial complete LEVDUSs (8.7%) and repeat LEVDUSs performed after an initial incomplete examination (8.2%; P ¼ .65).
Conclusions: Almost one-half of incomplete LEVDUSs are ordered in symptomatic patients. However, the large majority of patients with incomplete LEVDUS, even those with symptoms, do not have a followup examination but patients with repeat studies have a DVT diagnosis rate equivalent to patients with an initial complete examination, suggesting the need for quality assurance programs to ensure repeat studies are performed after incomplete LEVDUS, particularly in symptomatic patients.
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